Accrol Group Holdings plc Appoint New CFO Steven Townsley

Accrol Group Holdings plc
[shareaholic app="share_buttons" id_name="post_below_content"]

Accrol Group Holdings plc (LON:ACRL), the leading independent tissue converter in the UK, has today announced that Steven James Townsley, aged 50, has been appointed as Chief Financial Officer with effect from today, 11 June 2018.

Steve joins Accrol after concluding his role as Finance Director of Help-Link, the UK’s leading independent boiler installer, where he played an integral role in the successful turnaround and sale of the business. Prior to this, he gained 18 years’ experience in finance roles at a number of retail and distribution businesses, including Safeway, Exertis and Dixons, where he helped drive significant profitable growth, both organically and by acquisition, whilst maintaining a strong balance sheet.

Steve replaces Martin Leitch, who joined the Company as Interim Chief Financial Officer on 5 February 2018 to support the turnaround of the business, whilst the Board secured a permanent new Chief Financial Officer. Martin will remain with the business in the short term to effect an orderly handover.

Dan Wright, Chairman of Accrol Group Holdings plc, said: “I have seen Steve’s expertise and tenacity in action and his experience will be a strong asset, as we continue the turnaround of the business. His appointment strengthens Accrol’s new management team further and will help ensure that the business is best placed to continue to grow and develop its leading position with retail customers.”

Gareth Jenkins, CEO of Accrol, added: “We are very pleased that someone of Steve’s calibre has chosen to join us. The business will benefit considerably from his broad and relevant experience across a range of connected sectors and I welcome him to the team.”

“The Board thanks Martin for the valuable work he has completed in recent months, especially in the business turnaround plan which remains fully on schedule, and wishes him well in the future.”

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
Accrol Group Holdings plc (LON:ACRL) has announced the publication of a shareholder circular detailing terms of the Scheme. Learn more here.
Discover the latest results and overview of Accrol Group Holdings, the UK's top independent tissue converter, led by CEO Gareth Jenkins and CFO Chris Welsh.
In this interview, Gervais Williams, co-fund manager of Miton UK MicroCap Trust, discusses navigating the economic landscape and standout companies in 2024. Find out more here. #investment #microcap
Accrol Group Holdings plc has reported strong H1 FY24 results, with impressive growth in adjusted EBITDA and adjusted PBT. The company remains on track to meet expectations and has seen gains in market share. Furthermore, the private label segment of the UK tissue market continues to increase, and the sales of biodegradable wet wipes have been exceptionally strong. Accrol's outlook remains positive with expected further volume growth.
Accrol Group Holdings plc has reported strong performance in H1 FY24, with branded volumes rising by 45% and margins returning to pre-pandemic levels. The group is on track to deliver FY24 results in line with expectations and expects to outperform previous expectations for FY25.

Search

Search